A detailed history of Healthcare Of Ontario Pension Plan Trust Fund transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Healthcare Of Ontario Pension Plan Trust Fund holds 1,387,200 shares of STOK stock, worth $17 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,387,200
Previous 1,387,200 -0.0%
Holding current value
$17 Million
Previous $18.7 Million -0.0%
% of portfolio
0.06%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.03 - $17.52 $12.4 Million - $19.7 Million
1,123,500 Added 426.05%
1,387,200 $18.7 Million
Q1 2024

May 13, 2024

BUY
$4.12 - $14.17 $100,528 - $345,748
24,400 Added 10.2%
263,700 $3.56 Million
Q3 2023

Nov 13, 2023

SELL
$3.78 - $11.99 $160,650 - $509,575
-42,500 Reduced 15.08%
239,300 $942,000
Q2 2023

Aug 11, 2023

SELL
$7.93 - $13.82 $881,816 - $1.54 Million
-111,200 Reduced 28.3%
281,800 $3 Million
Q1 2023

May 12, 2023

SELL
$7.65 - $10.38 $269,280 - $365,376
-35,200 Reduced 8.22%
393,000 $3.27 Million
Q4 2022

Feb 13, 2023

SELL
$7.07 - $15.69 $3.31 Million - $7.35 Million
-468,700 Reduced 52.26%
428,200 $3.95 Million
Q3 2022

Nov 14, 2022

SELL
$12.56 - $22.53 $178,352 - $319,926
-14,200 Reduced 1.56%
896,900 $11.5 Million
Q2 2022

Aug 11, 2022

SELL
$10.36 - $23.93 $4.41 Million - $10.2 Million
-425,400 Reduced 31.83%
911,100 $12 Million
Q1 2022

May 12, 2022

BUY
$17.19 - $26.1 $23 Million - $34.9 Million
1,336,500 New
1,336,500 $28.1 Million
Q4 2021

Feb 11, 2022

SELL
$18.11 - $30.72 $92,361 - $156,672
-5,100 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$23.65 - $34.44 $120,615 - $175,644
5,100 New
5,100 $130,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $482M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.